₹ 82.05
0.47 (0.58%)
S
Shukra Pharmaceuticals
₹ 82.05
Shukra Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of Shukra Pharmaceuticals as of Q2 Sep 2026 stands at ₹0.29. This is a 3.33% fall quarter on quarter and 480.00% growth same quarter last year. For the FY2026 the EPS of Shukra Pharmaceuticals stands at ₹0.50. This is a 127.27% growth compared with FY2025.
Shukra Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

